TrialNature communications2017
Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.
Rajasekharan Somasundaram et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
94 papers cite itlatest 60 shown
this papertrialcites it